Generic Product News

Amoxicillin Tablets

Compared to:
Amoxil (GlaxoSmithKline)

Indication:
December 11, 2008—Greenstone, Pfizer's generic pharmaceutical subsidiary, announced that it introduced amoxicillin tablets in the 875-mg strength. The tablets are indicated in the treatment of infections due to susceptible strains of designated microorganisms in the following conditions: infections of the ears, nose, and throat; infections of the genitourinary tract; infections of the skin and skin structure; infections of the lower respiratory tract; gonorrhea, acute uncomplicated; and Helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence.

Dosage Form:
Tablets: 875 mg

For More Information:
www.greenstonellc.com

Galantamine Hydrobromide Extended-Release Capsules

Compared to:
Razadyne ER (Ortho-McNeil-Janssen)

Indication:
December 16, 2008—Watson Pharmaceuticals announced that its subsidiary, Watson Laboratories Inc, received FDA approval for its abbreviated new drug application for galantamine hydrobromide extended-release capsules, eq to 8, 16, and 24 mg (galantamine base). These capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type. Galantamine hydrobromide is a reversible, competitive acetylcholinesterase inhibitor. The recommended starting dose is 8 mg/day. The dose should be increased to the initial maintenance dose of 16 mg/day after a minimum of 4 weeks—a further increase to 24 mg/day should then be attempted.

Dosage Form:
Capsules: 8, 16, and 24 mg

For More Information:
www.watson.com

Pravastatin Sodium Tablets USP, 80 mg

Compared to:
Pravachol Tablets (ER Squibb & Sons)

Indication:
September 29, 2008—Teva Pharmaceuticals announced the introduction and availability of Pravastatin Sodium Tablets USP, 80 mg. With this new strength, Teva now offers the tablets in 10-, 20-, 40-, and 80-mg strengths. Therapy with pravastatin sodium tablets should be considered in those individuals at increased risk for atherosclerosis-related clinical events as a function of cholesterol level, the presence or absence or coronary heart disease, and other risk factors. It is one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis.

Dosage Form:
Tablets: 10, 20, 40, and 80 mg

For More Information:
www.tevausa.com
888-TEVA USA (888-838-2872)

Sumatriptan Succinate Injection

Compared to:
Imitrex injection (GlaxoSmithKline)

Indication:
November 6, 2008—Par Pharmaceutical announced that it will begin shipment of Sumatriptan Succinate Injection 4- and 6-mg starter kits and 4- and 6-mg prefilled syringe cartridges. Sumatriptan Succinate Injection is indicated for (1) the acute treatment of migraine attacks with or without aura and (2) the acute treatment of cluster headache episodes. It is not for use in the management of hemiplegic or basilar migraine.

Dosage Form:
Injection: 4- and 6-mg starter kits and 4- and 6-mg prefilled syringe cartridges

For More Information:
www.parpharm.com/products